References
Frost HM (1973) Bone remodeling and its relationship to metabolic bone diseases. C.C. Thomas, Springfield, IL
Delmas PD, Mann KG, Riggs BL (1983) Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone-Gla protein. Calcif Tissue Int. 35 (Suppl.) A59
Beresford JN, Gallagher JA, Poser J, Gowen M, Couch M, Yates AJP, Kanis JA, Russell RGG. (1983) Effects of the anabolic steroid, stanozolol, on human bone cellsin vitro. Calcif. Tissue Int. 35 (Suppl) A25
Yates AJP, Series JJ, Galloway J, Couch M, Gallacher JA, Sharrard M, Coulton L, Russell RGG, Kanis JA (1983) Action of stanozolol in osteoporosis. Calcif. Tissue Int. 35 (Suppl) A64
Parfitt AM, Duncan H. (1982) Metabolic bone disease affecting the spine.In: Rothman, R., Simeone, F. (eds) The Spine. W. B. Saunders, Philadelphia, 2nd ed
Hyldstrup L, Mogensen NB, McNair P, Jensen GF, Transbol I (1983) Changes in bone metabolism related to age and sex. Determination of 24 hours whole body retention of MDP in 125 normal persons. Calcif. Tissue Int. 35 (Suppl.) A32
Stepan J, Pospichal J, Povysil C, Kapitola J, Presl J, Pacovsky V (1983) Urinary hydroxyproline, acid phosphatase, and bone isoenzyme of serum alkaline phosphatase for early detecting of increased bone remodeling after oophorectomy. Calcif. Tissue Int. 35 (Suppl.) A59
Milhaud G, Benezeck-LeFevre M, Moukhtar MS (1982) Deficiency of calcitonin in age-related osteoporosis. Bimedicine 29:272–276
Taggart HMcA, Chesnut CHIII, Ivey JL, Baylink DJ, Sisom K, Huber MB, Roos BA. (1982) Deficient calcitonin response to calcium stimulation in postmenopausal osteoporosis. Lancet i:475–478
Stevenson JC (1981) Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of oestrogens. Lancet I:693–695
Body J-J, Heath H III (1983) Effects of age, sex, calcium, and total thyroidectomy on circulating monomeric calcitonin (CT) concentrations. Calcif Tissue Int. 35 (Suppl.) A45
Cavallini AR, Malfaccini M, Pansini F, Bettocchi S, Jr, Mollica G, Bagni B. (1983) Effect of ovariectomy on blood calcitonin levels. Calcif. Tissue Int. 35 (Suppl) A68
Duursma SA, Bijsma JWJ, van Paassen HC, van Buul-Offers SC (1983) Somatomedin, bone metabolism and oestrogen substitution. Calcif. Tissue Int. 35 (Suppl) A56
Jensen GF (1983) Smokers bones revisited. An epidemiologic approach. Calif. Tissue Int. 35 (Suppl.) A71
Frost HM (1979) Treatment of osteoporosis by manipulation of coherent bone cell populations. Clin. Orthop. 143:227–244
Parfitt AM (1980) The morphologic basis of bone mineral measurements: transient and steady state effects of treatment in osteoporosis. Editorial, Mineral and Electrolyte Metab. 4:273–287
Marie PJ, Rasmussen H, Kuntz D, Caulin F (1983) Effects of phosphate, calcitonin and combined therapy on bone in postmenopausal osteoporosis. Calcif. Tissue Int. 35 (Suppl) A11
Harrison JE, McNeill KG, Sturtridge WC, Bayley TA, Murray TM, Williams C, Tam C, Fornasier V (1981) Three-year changes in bone mineral mass of postmenopausal osteoporotic patients based on neutron activation analysis of the central third of the skeleton. J. Clin. Endocrinol. Metab. 52:751–758
Baud CA, Courvoisier B, Tochon-Danguy HJ, Very JM (1983) Changes in bone mineral following therapy of osteoporosis with fluoride. Calcif. Tissue Int. 35 (Suppl) A18
Krolner B, Toft B, Nielsen SP, Tondervold E (1983) Physical exercise as prophylaxis against involutional vertebral bone loss: a controlled trial. Clin. Sci. 64:541–546
Rights and permissions
About this article
Cite this article
Milhaud, G., Christiansen, C., Gallagher, C. et al. Pathogenesis and treatment of postmenopausal osteoporosis. Calcif Tissue Int 35, 708–711 (1983). https://doi.org/10.1007/BF02405109
Issue Date:
DOI: https://doi.org/10.1007/BF02405109